Impax Asset Management Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.81M | Buy |
23,175
+5,106
| +28% | +$399K | 0.01% | 231 |
|
|
2025
Q1 | $1.31M | Buy |
18,069
+621
| +4% | +$45K | 0.01% | 240 |
|
|
2024
Q4 | $1.29M | Buy |
17,448
+4,484
| +35% | +$332K | 0.01% | 262 |
|
|
2024
Q3 | $855K | Buy |
12,964
+5,164
| +66% | +$341K | ﹤0.01% | 293 |
|
|
2024
Q2 | $720K | Hold |
7,800
| – | – | ﹤0.01% | 285 |
|
|
2024
Q1 | $745K | Hold |
7,800
| – | – | ﹤0.01% | 296 |
|
|
2023
Q4 | $595K | Buy |
+7,800
| New | +$595K | ﹤0.01% | 332 |
|